PHARMACY

Camber announces plans for 2025 market intros
The company is set to launch a lineup of specialty medications and generic oncology products, with plans to introduce 45 to 50 new generic products throughout the year.
Cardinal Health launches ordering portal for cell, gene therapies
Advanced Therapy Connect is a simplified ordering and reporting process for cell and gene therapy products, the company said.

NACDS Regional Chain Conference emphasizes industry’s resolve to advocate, innovate amid change

NACDS said its first conference of 2025 kicked off with chains and suppliers working together to meet Americans’ needs.
FDA approves Alembic’s generic Rexulti

Brexpiprazole is used as an adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults, and in treatment of schizophrenia in adults and pediatric patients ages 13 years and older.
Teva partners with Klinge Biospharma, Formycon for Eylea biosimilar candidate in Europe, Israel

Eylea is used to treat neovascular age-related macular degeneration and other severe retinal diseases.
US Appeals Court reinstates pause on MSN's generic of Novartis' Entresto

There are no generic versions of Entresto available in the United States.
DHL Supply Chain acquires Inmar Supply Chain Solutions

With the acquisition, DHL Supply Chain expands its reverse logistics solutions, becoming the largest provider of returns processing in North America.
NACDS kicks off Health Starts Here in 2025 campaign

NACDS is focusing on the solutions that America’s pharmacies offer to support the health and well-being of communities nationwide.
XiFin releases findings from 2025 Pharmacy Survey

The XiFin survey offers a forward-looking snapshot of how pharmacies are preparing for and adapting to a rapidly changing healthcare landscape.
Lupin launches generic Minzoya

Generic Minzoya is indicated for use by women of reproductive potential to prevent pregnancy.